CME Group Inc. (NASDAQ:CME) HOLD
CME Group is an elite, near-monopoly derivatives exchange, but the price is full at roughly twenty-three times earnings with no margin of safety, the tape is in a downtrend below the fifty and two-hundred-day averages, and Q2 earnings land in six days. Every horizon reads hold: a great business at the wrong entry. Accumulate on a pullback, not here.
Re-presenting the Donatien Investment report on CME Group (NASDAQ:CME), dated 16 July 2026, at US$246.27. Short HOLD, medium HOLD, long HOLD.
A toll booth on global finance
CME runs the world's largest derivatives marketplace, and it clears what it trades. It charges a small fee on every futures and options contract in interest rates, equity indices, energy and metals, then guarantees settlement through its clearing house. The moat is a near-monopoly in US rate and index futures: once liquidity, open interest and margin efficiency pool on one venue, traders cannot easily leave. It is exceptionally capital-light, with operating margins above sixty-five per cent, almost no capital spending, and it returns nearly all its cash through a regular dividend plus a variable year-end special dividend.
Full price, no margin of safety
On valuation the quality is priced in. The clean price-to-earnings multiple is about twenty-three times against a warranted multiple of roughly nineteen times, a ratio of one-point-two-two, which lands in the full band with no margin of safety. The price-earnings-to-growth ratio of about two-and-a-half says you are paying up for durability, not for growth. Analysts see a median target near three-hundred-nine dollars, but the grades are split fifteen buy, sixteen hold, five sell. Full valuation means this is not a valuation entry until the price pulls back.
Why hold: the tape and the print
The tape is the binding constraint. CME has de-rated about twenty-five per cent from its three-hundred-twenty-nine dollar high to two-hundred-forty-six, and it trades below both its fifty-day at two-hundred-sixty-two and its two-hundred-day at two-hundred-seventy-nine. The daily and weekly trends are downtrends with a support breakdown; only the intraday frames are green, which is a bounce, not a turn. No technical entry group is met, and Q2 earnings land in six days on the twenty-second of July, a binary print. That combination caps timing and holds every horizon.
What could go wrong
Volatility normalises — ADV and float income fade. FMX takes measurable Treasury-futures share. An earnings miss into a downtrend, earnings in 6 days.
Risk vs Reward
The report weights three twelve-month paths to a modest, base-case-led expected return. The base case, most likely at fifty-five per cent, sees CME around two-hundred-seventy dollars as the quality compounder grinds higher on roughly five-to-six per cent earnings growth, about nine per cent above today. The bull at twenty-five per cent reaches three-hundred-fifteen dollars if elevated volatility persists and a clean Q2 beat re-rates the multiple. The bear at twenty per cent takes it to two-hundred-five dollars if volatility normalises and FMX erodes the moat premium. The probability-weighted fair value is approximately two-hundred-sixty-eight dollars, a positive but unremarkable return that leans on the base case, which is why all three horizons read hold rather than buy.
The verdict
The bottom line: an elite, near-monopoly exchange at a full valuation, in a downtrend below its key moving averages, with a binary earnings print six days away. Great business, wrong entry. It is a hold across every horizon; the disciplined move is to accumulate on a pullback toward support, not to chase it here. This is analysis, not financial advice — always do your own research.
Read the full report on donatien.ca →
